GILD DMA
As of date:11/25/2020
GILD stock price:59.50
GILD 50 DMA:61.42
GILD 200 DMA:69.65
GILD MACD (200-50):8.23

Also see:
GILD Market Cap History
GILD Shares Outstanding History
GILD YTD Return
GILD RSI
GILD MACD
GILD Technical Analysis

Bullish Two Hundred Day Moving Average Cross - PTR
Wednesday, November 25, 5:38 PM


DermTech Breaks Above 200-Day Moving Average - Bullish for DMTK
Wednesday, November 25, 5:37 PM


Wingstop (WING) Shares Cross Below 200 DMA
Wednesday, November 25, 11:43 AM


Notable Two Hundred Day Moving Average Cross - CTSO
Wednesday, November 25, 11:43 AM


YI Makes Notable Cross Below Critical Moving Average
Wednesday, November 25, 11:42 AM


FE Stock Crowded With Sellers
Wednesday, November 25, 11:38 AM


Stratasys Breaks Above 200-Day Moving Average - Bullish for SSYS
Wednesday, November 25, 11:33 AM


GHG Makes Notable Cross Below Critical Moving Average
Wednesday, November 25, 11:33 AM


Thyssen Krupp Breaks Above 200-Day Moving Average - Bullish for TYEKF
Tuesday, November 24, 4:39 PM


Cerus Breaks Below 200-Day Moving Average - Notable for CERS
Tuesday, November 24, 4:37 PM


Dorchester Minerals Breaks Above 200-Day Moving Average - Bullish for DMLP
Tuesday, November 24, 4:32 PM


BIOX Crosses Below Key Moving Average Level
Tuesday, November 24, 4:17 PM


ENB Makes Bullish Cross Above Critical Moving Average
Tuesday, November 24, 4:07 PM


Bullish Two Hundred Day Moving Average Cross - INGR
Tuesday, November 24, 4:07 PM


FDP Makes Bullish Cross Above Critical Moving Average
Tuesday, November 24, 4:06 PM


More Technical Analysis News

GILD DMAGILD MACD
Gilead Sciences is a research-based biopharmaceutical company that discovers, develops and commercializes medicines. Co.'s primary areas of focus include viral diseases, inflammatory and fibrotic diseases and oncology. Co.'s products include: Biktarvy for the treatment of HIV-1 infection in certain patients; Vosevi®, a single tablet regimen of sofosbuvir, velpatasvir and voxilaprevir for the re-treatment of chronic hepatitis C virus infection in adults; Vemlidy® for the treatment of chronic hepatitis B virus infection in adults with compensated liver disease; and Yescarta (axicabtagene ciloleucel) for the treatment of adult patients with relapsed or refractory large B-cell lymphoma.

When researching a stock like Gilead Sciences, many investors are the most familiar with Fundamental Analysis — looking at a company's balance sheet, earnings, revenues, and what's happening in that company's underlying business. Investors who use Fundamental Analysis to identify good stocks to buy or sell can also benefit from GILD Technical Analysis to help find a good entry or exit point. Technical Analysis is blind to the fundamentals and looks only at the trading data for GILD stock — the real life supply and demand for the stock over time — and examines that data in different ways. One of those ways is to calculate a Simpe Moving Average ("SMA") by looking back a certain number of days. One of the most popular "longer look-backs" is the GILD 200 day moving average ("GILD 200 DMA"), while one of the most popular "shorter look-backs" is the GILD 50 day moving average ("GILD 50 DMA"). A chart showing both of these popular moving averages is shown on this page for Gilead Sciences.
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks

10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Quotes delayed 20 minutes
Get Free SEC filing alerts for GILD:
GILD SEC Filing Email Alerts ServiceExternal link
Video: Technical Analysis


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Gilead Sciences (GILD) is categorized under the Healthcare sector; to help you further research DMA, below are some other companies in the same sector:

HCA DMA
HOLX DMA
HSIC DMA
IDXX DMA
ILMN DMA
INCY DMA
IQV DMA
ISRG DMA
JNJ DMA
LH DMA
More Healthcare companies »

 

GILD DMA | www.StockDMA.com | Copyright © 2019 - 2020, All Rights Reserved

Nothing in StockDMA.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.